PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsArray Biopharma
Array Biopharma(ARRY)
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is a subsidiary of Pfizer.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
BraftoviEncorafenib2018-06-272029-2033
Colorectal neoplasms
,
Melanoma
MektoviBinimetinib2018-06-272023-2033
Melanoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Binimetinib
colorectal neoplasms
,
colonic neoplasms
,
rectal neoplasms
,
gastrointestinal stromal tumors
,
disease progression
,
gene rearrangement
,
bcr-abl positive chronic myelogenous leukemia
,
lung neoplasms
,
non-small-cell lung carcinoma
,
melanoma
,
neoplasms
,
leukemia
,
myeloid leukemia
,
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
,
plexiform neurofibroma
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
cutaneous malignant melanoma
,
multiple myeloma
,
plasma cell neoplasms
,
myeloid leukemia acute
,
biliary tract neoplasms
,
lymphoma
Encorafenib
liver diseases
,
hepatic insufficiency
,
healthy volunteers/patients
,
brain neoplasms
,
neoplasms
,
neoplasm metastasis
,
non-small-cell lung carcinoma
,
colonic neoplasms
,
lung neoplasms
,
adenocarcinoma
,
colorectal neoplasms
,
biliary tract neoplasms
,
melanoma
Sacituzumab
urologic neoplasms
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
triple negative breast neoplasms
Ivuxolimab
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
Utomilumab
carcinoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
Gilvetmab
small cell lung carcinoma
Varlitinib
pancreatic neoplasms
,
neoplasms
Buparlisib
ovarian neoplasms
,
gastrointestinal stromal tumors
,
small cell lung carcinoma
,
nasopharyngeal carcinoma
,
squamous cell carcinoma
,
squamous cell neoplasms
,
nasopharyngeal neoplasms
,
laryngeal neoplasms
,
hypopharyngeal neoplasms
,
b-cell lymphoma marginal zone
,
waldenstrom macroglobulinemia
,
renal insufficiency
,
primary myelofibrosis
,
liver diseases
,
hepatic insufficiency
,
castration-resistant prostatic neoplasms
,
ovarian epithelial carcinoma
,
pancreatic neoplasms
,
stomach neoplasms
,
adenocarcinoma
,
healthy volunteers/patients
,
colonic neoplasms
,
neoplasms
,
glioblastoma
,
recurrence
,
non-small-cell lung carcinoma
,
lung neoplasms
,
prostatic neoplasms
,
lymphoma
,
triple negative breast neoplasms
,
follicular lymphoma
,
mantle-cell lymphoma
,
b-cell lymphoma
,
leukemia
,
carcinoma
,
endometrial neoplasms
,
brain neoplasms
,
large b-cell lymphoma diffuse
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
squamous cell carcinoma of head and neck
,
colorectal neoplasms
,
melanoma
,
basal cell carcinoma
,
skin neoplasms
,
basal cell nevus syndrome
,
basal cell neoplasms
,
thymoma
,
thymus neoplasms
,
uterine cervical neoplasms
,
transitional cell carcinoma
,
cholangiocarcinoma
,
breast neoplasms
,
neoplasm metastasis
,
hereditary sensory and autonomic neuropathies
Edrecolomab
discoid lupus erythematosus
,
systemic lupus erythematosus
,
cutaneous lupus erythematosus
,
multiple myeloma
,
plasma cell neoplasms
,
healthy volunteers/patients
,
neoplasms
Serine
non-small-cell lung carcinoma
,
lung neoplasms
Bevifimod
peripheral arterial disease
,
intermittent claudication
,
peripheral vascular diseases
,
neoplasms
,
hypophosphatemic rickets
,
hemophilia b
,
pseudoxanthoma elasticum
,
genetic therapy
,
mucopolysaccharidosis iv
,
hemophilia a
,
lysosomal storage diseases
,
hematologic diseases
,
blood coagulation disorders
,
hemostatic disorders
,
inborn genetic diseases
,
hemorrhagic disorders
,
inherited blood coagulation disorders
,
coagulation protein disorders
,
phenylketonurias
FILANESIB
neoplasms
,
multiple myeloma
,
plasma cell leukemia
,
paraproteinemias
,
plasmacytoma
,
leukemia
,
plasma cell neoplasms
,
myeloid leukemia acute
,
myeloid leukemia
Nadide
healthy volunteers/patients
,
infections
,
acquired immunodeficiency syndrome
,
hepatitis c
,
non-small-cell lung carcinoma
,
neoplasms
,
bacterial infections
,
toxoplasmosis
,
hepatitis b
,
chronic hepatitis b
,
hepatitis
,
hepatitis a
,
ulcer
,
buruli ulcer
,
hiv infections
,
streptococcal infections
,
pneumococcal infections
,
fever
,
meningococcal infections
,
pneumococcal pneumonia
,
premature birth
,
sexually transmitted diseases
,
herpes simplex
,
prostatic hyperplasia
,
hyperplasia
Nepidermin
multiple myeloma
,
plasma cell neoplasms
,
plasmacytoma
Polyglycolic acid
non-small-cell lung carcinoma
,
pancreatic ductal carcinoma
,
lung neoplasms
,
hiv infections
,
acquired immunodeficiency syndrome
,
toxoplasmosis
,
cerebral toxoplasmosis
,
encephalitis
,
stomach neoplasms
,
thyroid neoplasms
,
glioma
,
melanoma
,
breast neoplasms
,
triple negative breast neoplasms
,
esophageal neoplasms
,
rheumatoid arthritis
,
neoplasm metastasis
,
diarrhea
,
systemic lupus erythematosus
,
colorectal neoplasms
,
colonic neoplasms
,
rectal neoplasms
,
neoplasms
,
liver neoplasms
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
rectal diseases
,
gastrointestinal diseases
,
intestinal neoplasms
,
digestive system diseases
,
colonic diseases
,
intestinal diseases
1
2
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use